RNAZ Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own RNAZ shares is 11, representing 1.99% of the company's common stock.

RENAISSANCE TECHNOLOGIES LLC, in the last quarter, reduced its stake in RNAZ by -100% restricting it's holding to 0 shares of worth nearly -. MORGAN STANLEY also lessened -100% of the RNAZ shares from its portfolio, reducing its holding to 0 shares of worth -. MILLENNIUM MANAGEMENT LLC also shunned RNAZ shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, WARBERG ASSET MANAGEMENT LLC increased its stake in RNAZ by 100% in the last quarter. The institutional holder raised its holding to 20 thousand shares having worth more than $6.77K. SHEETS SMITH WEALTH MANAGEMENT also added 140% more shares of RNAZ to its portfolio, raising its holding to 60 thousand shares of worth $20.31K. ONE68 GLOBAL CAPITAL, LLC also increased its RNAZ shares holding by 100% which brought its holding to 30.12 thousand shares worth $10.20K.

The insider with the most stakes in RNAZ is Dudley Robert Michael , Chief Executive Officer at the company. Additionally, RNAZ stock is highly held by Chief Financial Officer Fitzgerald Thomas A and N/A N/A among others.

Company executives, directors, and other insiders own 0.01% percent of TransCode Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which RNAZ insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which TransCode Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 TransCode Therapeutics, Inc. shares are held by insiders, which represents about 0.01% of RNAZ stock.

RNAZ Chief Executive Officer, Dudley Robert Michael holds the largest portfolio of the company's shares. RNAZ shares owned by Dudley total nearly 180.26 thousand.

RENAISSANCE TECHNOLOGIES LLC is the largest institutional owner in RNAZ which holds 0 shares worth - or 0% of the total RNAZ shares outstanding followed by STATE STREET CORP with ownership of 21.02 thousand shares representing 0.01% of the RNAZ ownership. WARBERG ASSET MANAGEMENT LLC is the third largest stakeholder with 20 thousand shares or 0.01% of the ownership worth more than $6.77K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the RNAZ is concerned, it is a stock which is not optionable.

Number of RNAZ shares short is 743.58K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 696.25K shares of RNAZ are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, RNAZ has 17.26M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for RNAZ is 0.5.